166 filings
Page 7 of 9
8-K
uatzc3
7 Nov 17
T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
12:00am
8-K
126c6h20sdx8d6cs5 gw
19 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
ji27x7
14 Sep 17
Other Events
12:00am
8-K
9svl0rpw48brlk9
11 Sep 17
Other Events
12:00am
8-K
gvoe6at4t7rm9
5 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
s2y4ur ehu
8 Aug 17
T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update
12:00am
8-K
4n7c92zr 4di
6 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9qofy64epymyk6o
5 May 17
T2 Biosystems Reports First Quarter 2017 Results and Corporate Update
12:00am
8-K
6lrl ss2t
4 May 17
Departure of Directors or Certain Officers
12:00am
8-K
e2wq4be1 a6j8lw
8 Mar 17
Condensed Consolidated Statements of Operations and Comprehensive Loss
12:00am
8-K
mqiejvtokr9nvu6sug
3 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
vh4i5r
16 Feb 17
T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results
12:00am
8-K
v6zzwd441v 3s3yv8opg
20 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
cpopvg30g8euk9klv4
11 Jan 17
T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress
12:00am
8-K
brmqfw0e8mcq
6 Jan 17
T2 Biosystems, Inc. Announces $50M Credit Facility
12:00am
8-K
f7s9 xaxmdqjh
4 Nov 16
T2 Biosystems Reports Third Quarter Results
12:00am
8-K
ledkthdo0cee0cnf8s
3 Nov 16
T2 Biosystems Announces Collaboration with Allergan to Develop the First Blood-Based Diagnostic Panel to Detect Antimicrobial Resistance
12:00am
8-K
1pjb70s ktx6
22 Sep 16
T2 Biosystems Announces 40 Million Dollar Equity Investment by Partner
12:00am
8-K
dvl4dpz4q 6f
7 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
rlcf4kcp94mh06l
3 Aug 16
T2 Biosystems Reports 2016 Second Quarter, Six-Month Results
12:00am